Yahoo India Web Search

Search results

    • Zydus barred from selling cancer biosimilar, for now

      The Economic Times· 3 hours ago

      The Delhi High Court has issued an interim injunction, restraining Zydus Lifesciences from selling its breast cancer drug Sigrima - a biosimilar version of Roche's Perjeta (pertuzumab) - in ...